Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Canadian General Investments: Investment Update - Unaudited
-
Park Aerospace Corp. Announces Date of Second Quarter Earnings Release and Conference Call
-
O-I Glass Announces Third Quarter 2026 Earnings Conference Call and Webcast
-
authID Announces Pricing of Up To $1,350,000 Private Placement Offering
-
Kite Realty Group to Report Third Quarter 2026 Financial Results on October 30, 2026
-
ONEOK Schedules Third-Quarter 2026 Conference Call and Webcast
-
Uniti Group Inc. To Report Third Quarter 2026 Financial Results and Host Conference Call
-
Sound Community Bank Named One of American Banker’s 2026 Most Powerful Women Led Teams in Banking
-
Merlin, Inc. To Participate in Upcoming Investor Conferences
-
Government Business Results Expands Public Sector Go-to-Market Services with New Partner Marketing Practice
-
Arqitech signs agreement with ThinkEquity to build a multi-asset platform under the ThinkEquity brand
-
Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
-
Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED
-
Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting
-
Polar Power Rejects Solidion All-Cash Offer for Company Assets
-
CTW to Announce Fiscal Year 2026 Financial Results on October 15 and Host Earnings Webinar on October 16
-
Neostellar Capital Corp. Announces Third Quarter 2026 Preliminary Investment Portfolio Update
-
Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121
-
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
-
NanoXplore Announces the Creation of an Advisory Board for Its Subsidiary VoltaXplore and Appoints Galvion Founder and Executive Chairman Jonathan Blanshay as Inaugural Member
-
Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
-
Adeia Renews IP License Agreement with Spectrum
-
Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026
-
Universal Health Services, Inc. Announces Date for Third Quarter 2026 Earnings Release and Conference Call
-
Mulvihill Canadian Bank ETF Declares Monthly Distribution
-
Premium Income Corporation Announces Monthly Distribution
-
Mulvihill Split Preferred Share ETF Declares Monthly Distribution
-
Premium Global Income Split Fund Declares Monthly Distribution
-
Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
-
DeFi Development Corp. to Host X Spaces Event: “August & September 2026 Recap & AMA”
-
Mulvihill Split Capital Share ETF Declares Monthly Distribution
-
Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution
-
BridgeBio and Community Partners Launch Nationwide ATTR-CM Education Effort Ahead of World Amyloidosis Day
-
Mulvihill Premium Yield Declares Monthly Fund Distribution for Its ETF Class
-
Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
DeFi Development Corp. to Host X Spaces Event: “August & September 2026 Recap & AMA”
-
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
-
ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development
-
iCell Gene Therapeutics Announces Upcoming Conference Presentations
-
Leonardo DRS Completes Training and Delivery of INOD Block III Thermal Weapon Sights for the Australian Army
-
OceanFirst Financial Corp. Schedules Third Quarter 2026 Earnings Conference Call
-
Major shareholder announcement - BlackRock, Inc.
-
WatchGuard Unveils Major Unified Security Platform® Innovations at IMPACT North America
-
Major Shareholder Announcement
-
Big Bear Gold Corp. Announces Change of Transfer Agent to Olympia Trust Company
-
Top Technology Executives Recognized at the 2026 BayAreaCIO ORBIE Awards
-
Environmental Toxins and Brain Health: Experts Explore Cognitive Decline, Alzheimer’s Research and Therapeutic Plasma Exchange
-
FDA Clears Motivista (CT-155), the First Authorized Treatment for Negative Schizophrenia Symptoms
-
Cerene® Cryotherapy Brings Free Mother-Daughter Period Education Brunch to Indianapolis Area
-
NCSBN Board of Directors Makes Appointments to Fill Vacancies on Board and Leadership Succession Committee
